BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q, Song Y, Duan X, Chang Y, Guo J. MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1. Biomed Res Int 2018;2018:9870693. [PMID: 29984257 DOI: 10.1155/2018/9870693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Gao Y, Bai L, Shang G. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20. Aging (Albany NY) 2020;13:2668-80. [PMID: 33411691 DOI: 10.18632/aging.202314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yang S, Wallach M, Krishna A, Kurmasheva R, Sridhar S. Recent Developments in Nanomedicine for Pediatric Cancer. J Clin Med 2021;10:1437. [PMID: 33916177 DOI: 10.3390/jcm10071437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sheng G, Gao Y, Yang Y, Wu H. Osteosarcoma and Metastasis. Front Oncol 2021;11:780264. [PMID: 34956899 DOI: 10.3389/fonc.2021.780264] [Reference Citation Analysis]
4 Marracino L, Fortini F, Bouhamida E, Camponogara F, Severi P, Mazzoni E, Patergnani S, D'Aniello E, Campana R, Pinton P, Martini F, Tognon M, Campo G, Ferrari R, Vieceli Dalla Sega F, Rizzo P. Adding a "Notch" to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach. Front Cell Dev Biol 2021;9:695114. [PMID: 34527667 DOI: 10.3389/fcell.2021.695114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yamada NO, Senda T. Circulating microRNA-92a-3p in colorectal cancer: a review. Med Mol Morphol 2021;54:193-202. [PMID: 33620640 DOI: 10.1007/s00795-021-00282-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cao S, Jiang L, Shen L, Xiong Z. Role of microRNA-92a in metastasis of osteosarcoma cells in vivo and in vitro by inhibiting expression of TCF21 with the transmission of bone marrow derived mesenchymal stem cells. Cancer Cell Int 2019;19:31. [PMID: 30804710 DOI: 10.1186/s12935-019-0741-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]